A retrospective study analysing outcomes and performing a predictive analysis after Cord Blood Transplantation in patients with Hurler Syndrome who received a Bu-PK MAC regimen
Latest Information Update: 26 Jul 2021
At a glance
- Drugs Alemtuzumab (Primary) ; Antithymocyte globulin (Primary) ; Busulfan (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Steroids
- Indications Graft-versus-host disease; Mucopolysaccharidosis I
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2021 New trial record